Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myMPNteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A myMPNteam Member asked a question 💭
TX

Not according to ETrisk.com platelet normalization does not equate to disease control. Studies have shown that commonly used therapies—aspirin, hydroxyurea (HU), and anagrelide—have minimal impact on the continuous clonal proliferation in the bone marrow
Common existing treatments—aspirin, HU, and anagrelide—do not modify the underlying biologic drivers of ET, leaving patients at risk for complications such as MF or AML.Despite advances in our understanding of ET, FDA-approved treatment options… read more

March 3
 · 
Reactions
A myMPNteam Member

No, it does not.

March 3
myMPNteam

Does platelet normalization mean the disease is controlled?

You've touched on an important distinction in ET treatment. Normalizing platelet counts doesn't necessarily mean controlling the underlying disease process itself.

Current treatments like aspirin, hydroxyurea, and anagrelide primarily focus on managing symptoms Show Full Answer

Does platelet normalization mean the disease is controlled?

You've touched on an important distinction in ET treatment. Normalizing platelet counts doesn't necessarily mean controlling the underlying disease process itself.

Current treatments like aspirin, hydroxyurea, and anagrelide primarily focus on managing symptoms and reducing complications like blood clots. They work by reducing platelet counts or preventing platelets from clumping together, which helps lower the risk of serious events like stroke or heart attack.

However, these medications don't address the root cause—the genetic mutations driving abnormal cell production in the bone marrow. This is why doctors focus more on preventing complications and managing symptoms rather than just bringing numbers down.

The goal of treatment is typically to:
- Prevent blood clots and bleeding
- Reduce symptom burden
- Lower risk of progression to myelofibrosis or acute leukemia

Success is measured by keeping you healthy and symptom-free, not just by normalizing lab values. Some people live normally with high platelet counts and don't need aggressive treatment if they're at low risk for complications.

This is why ongoing monitoring remains crucial even when platelet counts are controlled—to watch for disease progression and adjust treatment as needed.

March 3

Related Questions

View All
A myMPNteam Member asked a question 💭
Illinois City, IL

A myMPNteam Member asked a question 💭
TX

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In